1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
When investors think of biotech stocks, visions of Amgen (AMGN) and Gilead (
Our picks should deliver solid long-term gains with less drama than the racy tech and biotech stocks strutting in the limelight.
Making money in stocks amid an uncertain market (see our 2019 outlook) will require careful choices. It will be difficult...
More Investing News »